DISTINCT AND SEPARABLE ROLES FOR HISTONE METHYLTRANSFERASE EZH2 IN NEUROGENIC ASTROCYTES

被引：0
|
作者：
Lim, Daniel A. [1 ]
Hwang, William W. [1 ]
Salinas, Ryan D. [1 ]
Siu, Jason J. [1 ]
Kelley, Kevin W. [1 ]
Delgado, Ryan N. [1 ]
Paredes, Mercedes F. [1 ]
Alvarez-Buylla, Arturo [1 ]
Oldham, Michael C. [1 ]
Lim, Daniel A. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
10.1093/neuonc/nou206.63
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] CD38: Modulating Histone Methyltransferase EZH2 Activity in SLE
    Chakraborty, Paramita
    Mehrotra, Shikhar
    TRENDS IN IMMUNOLOGY, 2020, 41 (03) : 187 - 189
  • [42] The histone methyltransferase EZH2 is required for normal uterine development and function in mice
    Nanjappa, Manjunatha K.
    Mesa, Ana M.
    Medrano, Theresa I.
    Jefferson, Wendy N.
    DeMayo, Francesco J.
    Williams, Carmen J.
    Lydon, John P.
    Levin, Ellis R.
    Cooke, Paul S.
    BIOLOGY OF REPRODUCTION, 2019, 101 (02) : 306 - 317
  • [43] The histone methyltransferase EZH2 is a novel target of anticancer therapy in endometrial cancer
    Oki, Shinya
    Sone, Kenbun
    Oda, Katsutoshi
    Nishijima, Akira
    Takeuchi, Makoto
    Agapiti, Chuwa
    Asada, Kayo
    Makii, Chinami
    Kawana, Kei
    Osuga, Yutaka
    Fuji, Tomoyuki
    CANCER RESEARCH, 2016, 76
  • [44] Activated p53 suppresses the histone methyltransferase EZH2 gene
    Xiaohu Tang
    Michael Milyavsky
    Igor Shats
    Neta Erez
    Naomi Goldfinger
    Varda Rotter
    Oncogene, 2004, 23 : 5759 - 5769
  • [45] The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells
    Miele, Evelina
    Valente, Sergio
    Alfano, Vincenzo
    Silvano, Marianna
    Mellini, Paolo
    Borovika, Diana
    Marrocco, Biagina
    Po, Agnese
    Besharat, Zein Mersini
    Catanzaro, Giuseppina
    Battaglia, Giuseppe
    Abballe, Luana
    Zwergel, Clemens
    Stazi, Giulia
    Milite, Ciro
    Castellano, Sabrina
    Tafani, Marco
    Trapencieris, Peteris
    Mai, Antonello
    Ferretti, Elisabetta
    ONCOTARGET, 2017, 8 (40) : 68557 - 68570
  • [46] EFFECT OF HISTONE METHYLTRANSFERASE EZH2 INHIBITOR 3-DEAZANEPLANOCIN A (DZNEP) ON ERYTHROPOIESIS
    Fujiwara, T.
    Saito, H.
    Okitsu, Y.
    Fukuhara, N.
    Onishi, Y.
    Ishizawa, K.
    Ichinohasama, R.
    Harigae, H.
    HAEMATOLOGICA, 2013, 98 : 416 - 416
  • [47] The Histone Methyltransferase EZH2 Controls Drug Resistance in Acute Myeloid Leukemia (AML)
    Goellner, S.
    Agrawal-Singh, S.
    Schenk, T.
    Klein, H. -U.
    Rohde, C.
    Sauer, T.
    Lerdrup, M.
    Tavor, S.
    Stoelzel, F.
    Ehninger, G.
    Koehler, G.
    Dugas, M.
    Zelent, A.
    Thiede, C.
    Berdel, W. E.
    Hansen, K.
    Mueller-Tidow, C.
    ANNALS OF HEMATOLOGY, 2015, 94 : S77 - S78
  • [48] O-GlcNAcylation regulates the stability and enzymatic activity of the histone methyltransferase EZH2
    Lo, Pei-Wen
    Shie, Jiun-Jie
    Chen, Chein-Hung
    Wu, Chung-Yi
    Hsu, Tsui-Ling
    Wong, Chi-Huey
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (28) : 7302 - 7307
  • [49] Regulation of Erythropoiesis by Histone Methyltransferase EZH2 Inhibitor 3-Deazaneplanocin A (DZNep)
    Fujiwara, Tohru
    Saitoh, Haruka
    Okitsu, Yoko
    Fukuhara, Noriko
    Onishi, Yasushi
    Ishizawa, Kenichi
    Ichinohasama, Ryo
    Harigae, Hideo
    BLOOD, 2012, 120 (21)
  • [50] The Histone Methyltransferase EZH2 Controls Drug Resistance in Acute Myeloid Leukemia (AML)
    Goellner, S.
    Agrawal-Singh, S.
    Schenk, T.
    Klein, H. -U.
    Rohde, C.
    Sauer, T.
    Lerdrup, M.
    Tavor, S.
    Stoelzel, F.
    Ehninger, G.
    Koehler, G.
    Dugas, M.
    Zelent, A.
    Thiede, C.
    Berdel, W. E.
    Hansen, K.
    Mueller-Tidow, C.
    ANNALS OF HEMATOLOGY, 2015, 94 (SUPPL 1) : 77 - 78
12345